| Name | Tetrahexyldecyl ascorbate |
| Description | Tetrahexyldecyl ascorbate (BV-OSC) is a lipophilic precursor of ascorbic acid, a more stable and permeable form of vitamin C. It is a potent anti-photo-aging and anti-hyperpigmentation antioxidant that inhibits MMP enzyme activity. |
| In vitro | Tetrahexyldecyl ascorbate, either alone or in combination with AZ, was applied to human keratinocytes (HaCaT) and dermal fibroblasts (nHDF, aHDF), and incubated for 0.5 to 3 hours. After treatment, cell viability was assessed using CCK-8, ELISA, and gene chip technologies. The Results showed that Tetrahexyldecyl ascorbate reduced cell viability under oxidative stress, while its combination with AZ significantly enhanced cell activity. The combination therapy upregulated genes related to phospholipid homeostasis and keratinocyte differentiation, inhibited the expression of MMP1 and MMP7, and promoted collagen synthesis in dermal fibroblasts [1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pure form: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 5 mg/mL (4.43 mM), Sonication is recommended.
DMSO : 180 mg/mL (159.33 mM), Sonication is recommended.
|
| Keywords | Tetrahexyldecyl ascorbate | Oristar THA | Nikkol BV-OSC |
| Inhibitors Related | Rhamnose monohydrate | Doxycycline (hyclate) | Chondroitin sulfate | Doxycycline | Edaravone | Rutin | Glucosamine | Anethole | Meloxicam | Chloramphenicol | Rebamipide | p-Hydroxycinnamic acid |
| Related Compound Libraries | Bioactive Compound Library | Vitamin Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Bioactive Lipid Compound Library | GPCR Compound Library |
United States
